EMA Issues Advice On Lilly’s Bamlanivimab (LY-CoV555) Alone And Administered Together With Etesevimab (LY-CoV016) For The Treatment Of Confirmed COVID-19 In The European UnionFav Store – Herbal P… · 09:00 09 Mar 2021Eli Lilly and Company (NYSE: LLY) announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive scientific opinion fo… Read More
